- Home
- CVGI vs CRVO Comparison
CVGI vs CRVO Comparison
Compare CVGI & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVGI
- CRVO
- Stock Information
- Founded
- CVGI 2000
- CRVO 2001
- Country
- CVGI United States
- CRVO United States
- Employees
- CVGI N/A
- CRVO N/A
- Industry
- CVGI Auto Parts:O.E.M.
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- CVGI Consumer Discretionary
- CRVO Health Care
- Exchange
- CVGI Nasdaq
- CRVO Nasdaq
- Market Cap
- CVGI 70.3M
- CRVO 67.4M
- IPO Year
- CVGI 2004
- CRVO N/A
- Fundamental
- Price
- CVGI $1.97
- CRVO $8.85
- Analyst Decision
- CVGI
- CRVO Strong Buy
- Analyst Count
- CVGI 0
- CRVO 6
- Target Price
- CVGI N/A
- CRVO $19.17
- AVG Volume (30 Days)
- CVGI 100.2K
- CRVO 118.8K
- Earning Date
- CVGI 11-03-2025
- CRVO 11-11-2025
- Dividend Yield
- CVGI N/A
- CRVO N/A
- EPS Growth
- CVGI N/A
- CRVO N/A
- EPS
- CVGI N/A
- CRVO N/A
- Revenue
- CVGI $676,815,000.00
- CRVO $7,776,968.00
- Revenue This Year
- CVGI N/A
- CRVO N/A
- Revenue Next Year
- CVGI $7.19
- CRVO N/A
- P/E Ratio
- CVGI N/A
- CRVO N/A
- Revenue Growth
- CVGI N/A
- CRVO N/A
- 52 Week Low
- CVGI $0.81
- CRVO $1.80
- 52 Week High
- CVGI $3.57
- CRVO $20.63
- Technical
- Relative Strength Index (RSI)
- CVGI 62.57
- CRVO 42.79
- Support Level
- CVGI $1.76
- CRVO $9.61
- Resistance Level
- CVGI $1.83
- CRVO $10.48
- Average True Range (ATR)
- CVGI 0.09
- CRVO 0.61
- MACD
- CVGI 0.02
- CRVO -0.15
- Stochastic Oscillator
- CVGI 94.44
- CRVO 6.85
About CVGI Commercial Vehicle Group Inc.
Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.